Cited by 142Probiotics and Fermented FoodsGut microbiota and healthMicrobial Metabolites in Food Biotechnology

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Probiotics as Complementary Treatment for Metabolic Disorders

Open access

Le Barz, Mélanie, Anhê, Fernando F., Varin, Thibaut V., Desjardins, Yves, Levy, Emile, Roy, Denis, Urdaci, Maria C., Marette, André·2015·Diabetes & Metabolism Journal

DOI 10.4093/dmj.2015.39.4.291PMC PMC4543192

Open this paper in CoChat — free account Open PDF

Abstract

Recent studies have demonstrated beneficial effects of specific probiotics on alleviating obesity-related disorders.Here we aimed to identify probiotics with potential antiobesity activity among 88 lactic acid bacterial strains via in vitro screening assays, and a Lactobacillus plantarum strain K21 was found to harbor abilities required for hydrolyzing bile salt, reducing cholesterol, and inhibiting the accumulation of lipid in 3T3-L1 preadipocytes.Furthermore, effects of K21 on diet-induced obese (DIO) mice were examined.Male C57Bl/6J mice received a normal diet, high-fat diet (HFD), or HFD with K21 administration (10 9 CFU in 0.2 mL PBS/day) for eight weeks.Supplementation of K21, but not placebo, appeared to alleviate body weight gain and epididymal fat mass accumulation, reduce plasma leptin levels, decrease cholesterol and triglyceride levels, and mitigate liver damage in DIO mice.Moreover, the hepatic expression of peroxisome proliferator-activated receptor-𝛾 (PPAR-𝛾) related to adipogenesis was significantly downregulated in DIO mice by K21 intervention.We also found that K21 supplementation strengthens intestinal permeability and modulates the amount of Lactobacillus spp., Bifidobacterium spp., and Clostridium perfringens in the cecal contents of DIO mice.In conclusion, our results suggest that dietary intake of K21 protects against the onset of HFD-induced obesity through multiple mechanisms of action.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.4093/dmj.2015.39.4.291

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 Potential beneficial effects of probiotic supplementation against metabolic disorders. GPR, G protein-coupled receptor; SCFA, short-chain fatty acid; ChREBP, carbohydrate-responsive element-binding protein; SREBP, sterol regulatory element-binding protein; AMPK, AMP-activated protein kinase; ANGPTL4, angiopoietin-like protein 4; TJ, tight junction; AJ, adherens junction.CC BY-NC · PubMed Central

Fig. 2 Potential direct effects of probiotics to protect gut microbiota and intestinal barrier integrity. Obesogenic diet or "Western diet" alter gut microbiota population diversity and intestinal barrier integrity. Cross-talk between ingested probiotics, gut microbiota (commensal bacteria) and epithelial cells (1). Probiotics produce metabolites that could serve to increase both the diversity of commensal bacteria and the availability of nutrients used by intestinal epithelial cells (IEC). Commensal bacteria multiply and in turn, also produce metabolites that could be used by surrounding cells. In patients suffering from metabolic disorders, intestinal permeability is altered leading to an increase of low-grade inflammation and metabolic endotoxemia (2). Probiotics can increase production of tight- and adherens junction (TJ and AJ) proteins (3), improving gut permeability and inhibiting the passage of lipopolysaccharides (LPS) into systemic circulation that decreases metabolic endotoxemia. Moreover, probiotics express microorganism-associated molecular patterns (MAMPs) that could bind to host pattern recognition receptors (PRRs) located at cell surface of IEC (1) and dendritic cells (4), and induce the activation/inhibition of signaling pathways. For example (5), probiotics can stimulate dendritic cells leading to inhibition of pro-inflammatory CD4+ cell proliferation and activation of anti-inflammatory pathways (Treg and plasma cell proliferation, resulting in production of anti-inflammatory cytokines and IgA immunoglobulins (6), respectively). Mainly present in the mucus layer, IgA reinforce the protective role of mucosal barrier. Mucus production can also be increased by probiotics that stimulate goblet cells leading to activation of mucin gene expression and therefore production of mucin glycoproteins (7). Once assembled, these proteins are excreted and form the mucus layer, which acts as barrier against pathogen colonization. However, probiotics can also induce physical barrier against pathogens or produce bacteriocins that inhibits undesirable microorganism invasion (8). TLR, Toll-like receptor; NLR, NOD-like receptor; TNF-α, tumor necrosis factor α; IFN-γ, interferon γ; TGF-β, transforming growth factor β; IL-10, interleukin 10.CC BY-NC · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Untitled work
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
Human nutrition, the gut microbiome and the immune system
Kau, A. L., Ahern, P. P., Griffin, N. W., Goodman, A. L., & Gordon, J. I. (2011) · Nature · doi:10.1038/nature10213 · Cited by 2,588
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia
Cani, P. D., Neyrinck, A. M., Fava, F., Knauf, C., Burcelin, R., Tuohy, K. M., Gibson, G. R., & Delzenne, N. M. (2007) · Diabetologia · doi:10.1007/s00125-007-0791-0 · Cited by 1,770
Short-Chain Fatty Acids Activate GPR41 and GPR43 on Intestinal Epithelial Cells to Promote Inflammatory Responses in Mice
Kim, M. H., Kang, S. G., Park, J. H., Yanagisawa, M., & Kim, C. H. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.056 · Cited by 1,127
Short-Chain Fatty Acids Protect Against High-Fat Diet–Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation
den Besten, G., Bleeker, A., Gerding, A., van Eunen, K., Havinga, R., van Dijk, T. H., Oosterveer, M. H., Jonker, J. W., Groen, A. K., Reijngoud, D.-J., et al. (2015) · Diabetes · doi:10.2337/db14-1213 · Cited by 1,125
Probiotics and the gut microbiota in intestinal health and disease
Gareau, M. G., Sherman, P. M., & Walker, W. A. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.117 · Cited by 907
Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii , a commensal bacterium deficient in Crohn’s disease
Quévrain, E., Maubert, M.-A., Michon, C., Chain, F., Marquant, R., Tailhades, J., Miquel, S., Carlier, L., Bermúdez‐Humarán, L. G., Pigneur, B., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307649 · Cited by 901
Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice
Wang, J., Tang, H., Zhang, C., Zhao, Y., Derrien, M., Rocher, E., Vlieg, J. E. V. H., Strissel, K. J., Zhao, L., Obin, M. S., et al. (2014) · The ISME Journal · doi:10.1038/ismej.2014.99 · Cited by 843
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1521 · Cited by 793
Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp.
Kailasapathy, K., & Chin, J. J.-C. (2000) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2000.00886.x · Cited by 792
Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults
Parnell, J. A., & Reimer, R. A. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27465 · Cited by 749
Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion
Yadav, H., Lee, J.-H., Lloyd, J., Walter, P., & Rane, S. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.452516 · Cited by 709
The Impact of a Consortium of Fermented Milk Strains on the Gut Microbiome of Gnotobiotic Mice and Monozygotic Twins
McNulty, N. P., Yatsunenko, T., Hsiao, A., Faith, J. J., Muegge, B. D., Goodman, A. L., Henrissat, B., Oozeer, R., Cools-Portier, S., Gobert, G., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002701 · Cited by 559
The Gut as a Source of Inflammation in Chronic Kidney Disease
Lau, W. L., Kalantar‐Zadeh, K., & Vaziri, N. D. (2015) · The Nephron journals/Nephron journals · doi:10.1159/000381990 · Cited by 474
Challenges in the Addition of Probiotic Cultures to Foods
Champagne, C. P., Gardner, N. J., & Roy, D. (2005) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690590900144 · Cited by 471
Self-citation
Prebiotic Effects of Wheat Arabinoxylan Related to the Increase in Bifidobacteria, Roseburia and Bacteroides/Prevotella in Diet-Induced Obese Mice
Neyrinck, A. M., Possemiers, S., Druart, C., Van de Wiele, T., De Backer, F., Cani, P. D., Larondelle, Y., & Delzenne, N. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020944 · Cited by 465
Regulation of Obesity-Related Insulin Resistance with Gut Anti-inflammatory Agents
Luck, H., Tsai, S. J., Chung, J., Clemente‐Casares, X., Ghazarian, M., Revelo, X. S., Lei, H., Luk, C. T., Shi, S. Y., Surendra, A., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.03.001 · Cited by 389
Butyricicoccus pullicaecorum in inflammatory bowel disease
Eeckhaut, V., Machiels, K., Perrier, C., Romero, C., Maes, S., Flahou, B., Steppe, M., Haesebrouck, F., Sas, B., Ducatelle, R., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-303611 · Cited by 368
Cross-Feeding between Bifidobacterium longum BB536 and Acetate-Converting, Butyrate-Producing Colon Bacteria during Growth on Oligofructose
Falony, G., Vlachou, A., Verbrugghe, K., & Vuyst, L. D. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.01296-06 · Cited by 362
Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women
Sanchez, M., Darimont, C., Drapeau, V., Emady-Azar, S., Lepage, M., Rezzonico, E., Ngom-Bru, C., Berger, B., Philippe, L., Ammon-Zuffrey, C., et al. (2014) · British Journal of Nutrition · doi:10.1017/s0007114513003875 · Cited by 351
Self-citation
Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production
Vuyst, L. D., & Leroy, F. (2011) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2011.03.003 · Cited by 349
Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver Axis
Endo, H., Niioka, M., Kobayashi, N., Tanaka, M., & Watanabe, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063388 · Cited by 339
Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in Diet-Induced Obese Mice Is Associated with Gut Microbial Changes and Reduction in Obesity
Park, D.-Y., Ahn, Y.-T., Park, S.-H., Huh, C.-S., Yoo, S.-R., Yu, R., Sung, M.-K., McGregor, R. A., & Choi, M.-S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059470 · Cited by 317 · cited 1×
“POTENTIAL MECHANISMS OF ACTIONS Probiotic administration is frequently associated with important shifts in gut bacterial composition, along with beneficial effects on metabolism and inflammatory tone [16-18,21,22].”
Background
Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: Bacteriocins and conjugated linoleic acid
O'Shea, E. F., Cotter, P. D., Stanton, C., Ross, R. P., & Hill, C. (2012) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2011.05.025 · Cited by 305
Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low - Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db / db Mice
Everard, A., Matamoros, S., Geurts, L., Delzenne, N. M., & Cani, P. D. (2014) · mBio · doi:10.1128/mbio.01011-14 · Cited by 304
Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice
Ritze, Y., Bárdos, G., Claus, A., Ehrmann, V., Bergheim, I., Schwiertz, A., & Bischoff, S. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0080169 · Cited by 292
Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity
Chen, Z., Guo, L., Zhang, Y., L. Walzem, R., Pendergast, J. S., Printz, R. L., Morris, L. C., Matafonova, E., Stien, X., Kang, L., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72517 · Cited by 277
Gut Microbiota and Metabolic Disorders
Hur, K. Y., & Lee, M. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.3.198 · Cited by 273
Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin‐degradation in humanized rats
den Abbeele, P. V., Gérard, P., Rabot, S., Bruneau, A., Aidy, S. E., Derrien, M., Kleerebezem, M., Zoetendal, E. G., Smidt, H., Verstraete, W., et al. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02533.x · Cited by 267
Changes of the human gut microbiome induced by a fermented milk product
Veiga, P., Pons, N., Agrawal, A., Oozeer, R., Guyonnet, D., Brazeilles, R., Faurie, J., Vlieg, J. E. T. V. H., Houghton, L. A., Whorwell, P. J., et al. (2014) · Scientific Reports · doi:10.1038/srep06328 · Cited by 266
Regulation of the intestinal epithelial barrier by the apical junctional complex
Laukoetter, M. G., Bruewer, M., & Nusrat, A. (2006) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000203864.48255.4f · Cited by 264
Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes
Duan, F. F., Liu, J. H., & March, J. C. (2015) · Diabetes · doi:10.2337/db14-0635 · Cited by 263
Microbial modulation of insulin sensitivity
Khan, M. T., Nieuwdorp, M., & Bäckhed, F. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.006 · Cited by 260
Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease
Nabavi, S., Rafraf, M., Somi, M. H., Rad, A. H., & Jafarabadi, M. A. (2014) · Journal of Dairy Science · doi:10.3168/jds.2014-8500 · Cited by 238
Probiotics L. plantarum and L. curvatus in Combination Alter Hepatic Lipid Metabolism and Suppress Diet‐Induced Obesity
Yoo, S., Kim, Y., Park, D., Jung, U., Jeon, S., Ahn, Y., Huh, C., McGregor, R., & Choi, M. S. (2013) · Obesity · doi:10.1002/oby.20428 · Cited by 230
Anti-Obesity Effect of Lactobacillus gasseri BNR17 in High-Sucrose Diet-Induced Obese Mice
Kang, J.-H., Yun, S.-I., Park, M.-H., Park, J.-H., Jeong, S.-Y., & Park, H.-O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054617 · Cited by 230
Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice
Neyrinck, A. M., Hée, V. F. V., Piront, N., Backer, F. D., Toussaint, O., Cani, P. D., & Delzenne, N. M. (2012) · Nutrition and Diabetes · doi:10.1038/nutd.2011.24 · Cited by 223
Gut microbiota and metabolic disorders: how prebiotic can work?
Delzenne, N. M., Neyrinck, A. M., & Cani, P. D. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114512004047 · Cited by 175
Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice
Stenman, L. K., Waget, A., Garret, C., Klopp, P., Burcelin, R., & Lahtinen, S. J. (2014) · Beneficial Microbes · doi:10.3920/bm2014.0014 · Cited by 153
Non Digestible Oligosaccharides Modulate the Gut Microbiota to Control the Development of Leukemia and Associated Cachexia in Mice
Bindels, L. B., Neyrinck, A. M., Salazar, N., Taminiau, B., Druart, C., Muccioli, G. G., François, E., Blecker, C. S., Richel, A., Daube, G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131009 · Cited by 141
Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects
Hulston, C. J., Churnside, A. A., & Venables, M. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114514004097 · Cited by 140
Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases
Felice, C., Lewis, A., Armuzzi, A., Lindsay, J., & Silver, A. R. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13008 · Cited by 120
Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial
Minami, J.-I., Kondo, S., Yanagisawa, N., Odamaki, T., Xiao, J., Abe, F., Nakajima, S., Hamamoto, Y., Saitoh, S., & Shimoda, T. (2015) · Journal of Nutritional Science · doi:10.1017/jns.2015.5 · Cited by 114
Small Intestinal Alterations in Severely Obese Hyperglycemic Subjects
Verdam, F. J., Greve, J. W. M., Roosta, S., van Eijk, H. M. H., Bouvy, N. D., Buurman, W. A., & Rensen, S. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1333 · Cited by 105
Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications
de LeBlanc, A. D. M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16518 · Cited by 104
Exploring the influence of the gut microbiota and probiotics on health: a symposium report
Thomas, L. V., Ockhuizen, T., & Suzuki, K. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514001275 · Cited by 93
Effect ofLactobacillus plantarumStrain K21 on High-Fat Diet-Fed Obese Mice
Wu, C.-C., Weng, W.-L., Lai, W., Tsai, H.-P., Liu, W., Lee, M.-H., & Tsai, Y.-C. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/391767 · Cited by 92
Current Review of Genetically Modified Lactic Acid Bacteria for the Prevention and Treatment of Colitis Using Murine Models
de LeBlanc, A. D. M., del Carmen, S., Chatel, J., Miyoshi, A., Azevedo, V., Langella, P., Bermúdez‐Humarán, L. G., & LeBlanc, J. G. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/146972 · Cited by 72
Modulatory effects of a cranberry extract co-supplementation with Bacillus subtilis CU1 probiotic on phenolic compounds bioavailability and gut microbiota composition in high-fat diet-fed mice
Dudonné, S., Varin, T. V., Anhê, F. F., Dubé, P., Roy, D., Pilon, G., Marette, A., Levy, E. H., Jacquot, C., Urdaci, M. C., et al. (2015) · PharmaNutrition · doi:10.1016/j.phanu.2015.04.002 · Cited by 52
Self-citation
The effect of probiotic soy milk and soy milk on anthropometric measures and blood pressure in patients with type II diabetes mellitus: A randomized double-blind clinical trial.
Hariri, M., Salehi, R., Feizi, A., Mirlohi, M., Kamali, S., & Ghiasvand, R. (2015) · Europe PMC (PubMed Central) · Cited by 52
The triglyceride-lowering effect of supplementation with dual probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032: reduction of fasting plasma lysophosphatidylcholines in nondiabetic and hypertriglyceridemic subjects
Ahn, H. Y., Kim, M., Ahn, Y.-T., Sim, J.-H., Choi, I.-D., Lee, S.-H., & Lee, J. H. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.05.002 · Cited by 44 · cited 1×
“Nevertheless, storage of excess FA is the result of unbalanced lipid absorption involving LPL and lipid catabolism [29].”
Background
Hepatic molecular responses to Bifidobacterium pseudocatenulatum CECT 7765 in a mouse model of diet-induced obesity
Moya-Pérez, Á., Romo‐Vaquero, M., Tomás-Barberán, F. A., Sanz, Y., & García‐Conesa, M. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.04.011 · Cited by 35
Effects of probioticLactobacillus rhamnosusGG andPropionibacterium freudenreichiissp.shermaniiJS supplementation on intestinal and systemic markers of inflammation in ApoE*3Leiden mice consuming a high-fat diet
Oksaharju, A., Kooistra, T., Kleemann, R., van Duyvenvoorde, W., Miettinen, M., Lappalainen, J., Lindstedt, K. A., Kovanen, P. T., Korpela, R., & Kekkonen, R. A. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512004801 · Cited by 31
Interactions Between Probiotic Dairy Propionibacteria and the Intestinal Epithelium
Cousin, F., Deutsch, S., Chaia, A. P., Foligné, B., & Jan, G. (2012) · Current Immunology Reviews · doi:10.2174/157339512800671976 · Cited by 11

Research works printed but not linked: 4

Wu, 2015, Evid Based Complement Alternat Med, 2015, 391767
Hariri, 2015, ARYA Atheroscler, 11, 74
Quevrain, 2015, Gut
Dudonne, 2015, PharmaNutrition

Sorted by citations

Benefaction of probiotics for human health: A review
George Kerry, R., Patra, J. K., Gouda, S., Park, Y., Shin, H.-S., & Das, G. (2018) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.01.002 · Cited by 898
Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
Mohammad, S., & Thiemermann, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594150 · Cited by 585
Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials
Kristensen, N. B., Bryrup, T., Allin, K. H., Nielsen, T., Hansen, T. H., & Pedersen, O. (2016) · Genome Medicine · doi:10.1186/s13073-016-0300-5 · Cited by 561
Immunomodulatory Effects of Probiotics on Cytokine Profiles
Azad, M. A. K., Sarker, M., & Wan, D. (2018) · BioMed Research International · doi:10.1155/2018/8063647 · Cited by 521
Microbiota-gut-brain axis: Modulator of host metabolism and appetite
van de Wouw, M., Schellekens, H., Dinan, T. G., & Cryan, J. F. (2017) · The Journal of Nutrition · doi:10.3945/jn.116.240481 · Cited by 461

See all 142

Authors: Le Barz, M., Anhê, F. F., Varin, T. V., Desjardins, Y., Levy, E., Roy, D., Urdaci, M. C., & Marette, A.
Affiliations: Department of Medicine, Faculty of Medicine, Cardiology Axis of the Québec Heart and Lung Institute, Québec, QC, Canada.
Institut universitaire de cardiologie et de pneumologie de Québec (CA)
Université Laval (CA)
Centre Hospitalier Universitaire Sainte-Justine (CA)
University of Bordeaux, UMR 5248, CBMN, Bordeaux, France.
Corresponding author: Marette, André
ORCID: Anhê, Fernando F.
Desjardins, Yves
Levy, Emile
Roy, Denis
Marette, André
Venue: Diabetes & Metabolism Journal
Publisher: Korean Diabetes Association
Published: 2015
Volume: 39
Issue: 4
Pages: 291
ISSN: 2233-6079 (ISSN-L)
2233-6087
DOI: 10.4093/dmj.2015.39.4.291
PMC: PMC4543192
OpenAlex: W2167419149
Cited by: 142
References: 61
Citations by year: 2026: 8 · 2025: 18 · 2024: 10 · 2023: 9 · 2022: 14 · 2021: 7 · 2020: 15 · 2019: 14 · 2018: 14 · 2017: 15 · 2016: 15 · 2015: 3
FWCI: 2.01
Type: journal article
Language: en
Update notices: erratum (2015-10-22)
Open access: gold
doi.org
Licence: cc-by-nc
creativecommons.org/licenses/by-nc/3.0/ (tdm)
Locations: Diabetes & Metabolism Journal (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion)
Topics: Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
Keywords: probiotics, Lactobacillus plantarum, anti-obesity, diet-induced obesity, high-fat diet, bile salt hydrolysis, cholesterol lowering, leptin, hepatic steatosis, PPARγ, intestinal permeability, gut microbiota, 3T3-L1 preadipocytes, metabolic disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Probiotics as Complementary Treatment for Metabolic Disorders

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks